Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 22
Page 363
... pattern . This proposal is said to have two disadvantages : First : " Wichterle fails to disclose ... the use of an intermittent pattern that leaves a substantial portion within the interstices of the pattern uncoloured . Nor does ...
... pattern . This proposal is said to have two disadvantages : First : " Wichterle fails to disclose ... the use of an intermittent pattern that leaves a substantial portion within the interstices of the pattern uncoloured . Nor does ...
Page 365
... pattern " . The reader is told that the plate is made by a well - known method . The description of the process which I need not reproduce in full , refers to the possibility of the printing step being repeated “ using different patterns ...
... pattern " . The reader is told that the plate is made by a well - known method . The description of the process which I need not reproduce in full , refers to the possibility of the printing step being repeated “ using different patterns ...
Page 366
... pattern appears continuous when viewed by an onlooker having 20-20 vision at a distance of 1.5m ( 5ft ) . D The ... pattern deposited over said entire iris section , [ 5 ] characterised in that said pattern comprises coloured dots ...
... pattern appears continuous when viewed by an onlooker having 20-20 vision at a distance of 1.5m ( 5ft ) . D The ... pattern deposited over said entire iris section , [ 5 ] characterised in that said pattern comprises coloured dots ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word